## Abstract The synthesis of 2‐([4‐^18^F]fluorophenyl)benzimidazole, which has potential to be used as a building block for many endogenous and pharmaceutical compounds, is reported. A range of solvents and catalysts as well as conventional and microwave heating have been investigated to optimise t
Synthesis of 2-[(4-[18F]Fluorobenzoyloxy)methyl]-1,4-naphthalenedione from 2-hydroxymethyl 1,4-naphthoquinone and 4-[18F]fluorobenzoic acid using dicyclohexyl carbodiimide
✍ Scribed by Uwe Ackermann; Duanne Sigmund; Shinn Dee Yeoh; Angela Rigopoulos; Graeme O'Keefe; Glenn Cartwright; Jonathan White; Andrew M. Scott; Henri J. Tochon-Danguy
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- French
- Weight
- 355 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
2‐[(4‐[^18^F]Fluorobenzoyloxy)methyl]‐1,4‐naphthalenedione ([^18^F]1) was synthesised as a putative hypoxia imaging agent from 2‐hydroxymethyl 1,4‐naphthoquinone (7) and 4‐[^18^F]fluorobenzoic acid ([^18^F]8) using dicyclohexyl carbodiimide (DCC) to activate [^18^F]8. This coupling reaction was fast and gave quantitative yields. Further investigations are warranted on the use of DCC as a coupling agent in Positron Emission Tomography. The synthesis including HPLC purification and reformulation has been fully automated on a modified FDG synthesiser with two reactor vials. [^18^F]1 was produced in a radiochemical yield of 27 ± 5%, with a radiochemical purity of 97.5% and a specific activity of 78.4–134.5 GBq/µmol at the end of synthesis (n = 23). The total synthesis time including reformulation was 65 min. [^18^F]1 was found to be stable in plasma and saline, but underwent rapid metabolism in a phase 1 metabolite assay using rat S9 liver fractions. An in vivo evaluation of [^18^F]1 in transplanted, hypoxic SK‐RC‐52 tumour‐bearing BALB/c nude mice revealed the tumour‐to‐muscle ratio to be 2.4 ± 0.1 at 2 h post‐injection. Copyright © 2011 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract 3‐[[4hyphen;(4‐[^18^F]fluorophenyl)piperazin‐1‐yl] methyl] ‐1__H__‐pyrrolo[2,3‐b]pyridine, acandidate to image dopamine D~4~ receptors, was synthesised via electrophilic fluorination of a trimethylstannyl precursor with high specific radioactivity [^18^F]F~2~. The precursor was obtained
## Abstract We have synthesized __β__‐O‐D‐galactopyranosyl‐(1,4′)‐2′‐[^18^F]fluoro‐2′‐deoxy‐D‐glucopyranose (2′‐[^18^F]fluorodeoxylactose, ^18^FDL) using an enzymatic method starting from ^18^FDG in order to evaluate this compound with regard to its usefulness for __in vivo__ visualization of the e
## Abstract The novel sigma‐1 receptor PET radiotracer [^18^F]1‐(2‐fluoroethyl)‐4‐[(4‐cyanophenoxy)methyl]piperidine ([^18^F]WLS1.002, [^18^F]‐2) was synthesized (__n__=6) by heating the corresponding __N__‐ethylmesylate precursor in an anhydrous acetonitrile solution containing [^18^F]fluoride, Kr
## Abstract The neurotransmitter glutamate is thought to be crucially involved in a huge number of neurological and psychiatric disorders, such as Morbus Parkinson, Alzheimer's disease and schizophrenia. Aiming at an improved diagnostic tool for PET a new [^18^F]fluorine labelled NMDA receptor liga